The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
94187132 9418713 2 F 2008 20160808 20130725 20160817 EXP US-ASTRAZENECA-2013SE52466 ASTRAZENECA 78.00 YR F Y 85.30000 KG 20160817 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
94187132 9418713 1 PS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral U U 19810 10 MG BID
94187132 9418713 2 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral U U 19810 20 MG BID
94187132 9418713 3 SS PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral U U 19810 20 MG QOD
94187132 9418713 4 SS PRILOSEC OTC OMEPRAZOLE MAGNESIUM 1 Oral U U 0 MODIFIED-RELEASE TABLET
94187132 9418713 5 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 0 10 MG TABLET QD
94187132 9418713 6 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 10 MG DAILY GENERIC 0
94187132 9418713 7 SS MOVANTIK NALOXEGOL OXALATE 1 Oral 204760 12.5 MG TABLET QD
94187132 9418713 8 C DIOVAN VALSARTAN 1 Oral 0
94187132 9418713 9 C DIOVAN VALSARTAN 1 Oral 0
94187132 9418713 10 C LOPRESSOR METOPROLOL TARTRATE 1 Oral 0
94187132 9418713 11 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 0
94187132 9418713 12 C HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 7.5 325 MG 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
94187132 9418713 1 Nausea
94187132 9418713 2 Nausea
94187132 9418713 3 Nausea
94187132 9418713 4 Nausea
94187132 9418713 5 Blood cholesterol abnormal
94187132 9418713 6 Blood cholesterol abnormal
94187132 9418713 7 Constipation
94187132 9418713 8 Cardiac disorder
94187132 9418713 9 Hypertension
94187132 9418713 10 Cardiac disorder
94187132 9418713 11 Thyroid disorder
94187132 9418713 12 Pain

Outcome of event

Event ID CASEID OUTC COD
94187132 9418713 HO
94187132 9418713 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
94187132 9418713 Abdominal pain upper
94187132 9418713 Back pain
94187132 9418713 Body height decreased
94187132 9418713 Cough
94187132 9418713 Decreased appetite
94187132 9418713 Glaucoma
94187132 9418713 Incorrect dose administered
94187132 9418713 Intentional product misuse
94187132 9418713 Nausea
94187132 9418713 Nervousness
94187132 9418713 Off label use
94187132 9418713 Product use issue
94187132 9418713 Spinal disorder
94187132 9418713 Stress
94187132 9418713 Tension
94187132 9418713 Therapeutic response unexpected
94187132 9418713 Transient ischaemic attack
94187132 9418713 Visual acuity reduced
94187132 9418713 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
94187132 9418713 1 2008 0
94187132 9418713 2 2013 2013 0
94187132 9418713 3 201307 201307 0
94187132 9418713 5 2006 201606 0
94187132 9418713 6 201606 0
94187132 9418713 7 201607 0